In the News

Preliminary Results

November 23, 2007. London, UK – Nviro Cleantech plc (AIM:NVR), which commercialises "clean technologies", is pleased to announce its maiden preliminary results for the twelve months ended 30 September 2007.

Highlights
- Admittance to AIM on 6 August 2007, raising £7.5 million (before expenses) through the placing of 11.9 million new shares
- Joint venture established in China for the commercialisation of Nviro's clean combustion technology, Vertus, including a commitment for two reductive thermal units (RTPs)
- Memorandum of Understanding ("MOU")signed with CLP Power India Private Ltd to develop Vertus biomass and coal treatment applications in India
- Identified a further source of early potential revenues for Vertus RTP in the selling of carbon emission credits derived from biomass units
- Microrelease technology for recycling of medium density fibreboard (MDF) confirmed via an extensive, independent testing programme
- Laseair and Organotect programmes on schedule with prototype assembly at an advanced stage
- Two significant US-based appointments: Andrew Cosentino (Group Board) and Dr Ken Hughes (promotion to President of Vertus subsidiary)
- In the USA negotiations continue with a number of prospective clients in both the Power generation and the industrial sectors and are expected to bear fruit in commitments in 2008
- Pre-revenue company with a loss before tax of £4.195 million

Chris Every, CEO of Nviro Cleantech Plc, said: "Nviro has experienced an extremely busy and productive period since the successful AIM flotation in August. We have concentrated on operational and technical developments across our portfolio companies, laying the foundations for strong future growth. Our primary focus has been to establish key working partnerships in coal and biomass applications for our lead subsidiary Vertus and we are delighted to have secured an MOU with CLP India while negotiations continue in other key territories. In testing, our second portfolio technology Microrelease, continues to perform well, while prototyping for both Laseair and Organotect is on schedule. Furthermore, the strengthening of our senior team will also be fundamental in delivering on the exciting growth strategy stated in our AIM Admission document."

A full set of these preliminary results can be downloaded in a PDF format

For further information:

Nviro Cleantech plc
Chris Every, Chief Executive Officer
Tel: +44 (0) 20 7451 2473
cevery@nvirocleantech.com

Grant Thornton Corporate Finance - Nominated Adviser
Fiona Owen - fiona.owen@gtuk.com
Troy MacDonald - troy.macdonald@gtuk.com
Tel: +44 (0) 20 7383 5100

Fairfax I.S. PLC - Broker
Ewan Leggat - eleggat@fairfaxis.com
Tel: +44 (0) 20 7598 5369

Media enquiries:

Abchurch
Justin Heath or Georgina Bonham - georgina.bonham@abchurch-group.com
Tel: +44 (0) 20 7398 7715

back to top